Although there has not been an official statement from the UKgovernment, it now seems fairly unlikely - according to sources close to both industry and the Department of Health - that original pack dispensing of medicines will be turned down.
It had seemed that there was general consensus between the pharmaceutical industry, the medical professions, the government and the Medicines Control Agency on the benefits of original packs, which would contain patient leaflets in order to increase safety and compliance in the use of drugs, and reduce waste.
ABPI Concern Mindful of the situation, the Association of the British Pharmaceutical Industry put out a statement earlier this month, in which ABPI president Peter Read registered his concern over the lack of progress by the DoH. Dr Read noted that there was close agreement between the British Medical Association, the Royal Pharmaceutical Society of Great Britain, the Royal College of General Practitioners and the industry on the need for the introduction of these packs, and this has been supported by considerable effort from the MCA to approve the new packs and leaflets.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze